HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 282, Issue 29, 21134-21144, July 20, 2007

This Article Full Text Full Text (PDF) Supplemental Data All Versions of this Article: 282/29/21134    most recent M700083200v1 Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Martens, G. A. Articles by Pipeleers, D. Search for Related Content PubMed PubMed Citation Articles by Martens, G. A. Articles by Pipeleers, D. Social Bookmarking                      What's this?

Specificity in Beta Cell Expression of L-3-Hydroxyacyl-CoA Dehydrogenase, Short Chain, and Potential Role in Down-regulating Insulin Release^*

Geert A. Martens, Annelies Vervoort, Mark Van de Casteele, Geert Stangé, Karine Hellemans, Hong Vien Van Thi, Frans Schuit^¶, and Daniël Pipeleers¹

From the Diabetes Research Center, Brussels Free University-VUB, Laarbeeklaan 103, B-1090 Brussels, the Laboratory of Pediatrics, Brugmann Hospital, Brussels Free University-ULB, B-1020 Brussels, and the ^¶Gene Expression Unit, Department of Molecular Cell Biology, Katholieke Universiteit Leuven-KUL, B-3000 Leuven, Belgium

A loss-of-function mutation of the mitochondrial -oxidation enzyme L-3-hydroxyacyl-CoA dehydrogenase, short chain (HADHSC), has been associated with hyperinsulinemic hypoglycemia in man. It is still unclear whether loss of glucose homeostasis in these patients (partly) results from a dysregulation of beta cells. This study examines HADHSC expression in purified rat beta cells and investigates whether its selective suppression elevates insulin release. Beta cells expressed the highest levels of HADHSC mRNA and protein of all examined tissues, including those with high rates of mitochondrial -oxidation. On the other hand, beta cells expressed relatively low levels of other -oxidation enzymes (acyl-CoA dehydrogenase short, medium, and long chain and acetyl-coenzyme A acyltransferase 2). HADHSC expression was sequence-specifically silenced by RNA interference, and the effects were examined on glucose-stimulated insulin secretion following 48–72 h of suppression. In both rat beta cells and in the beta cell line INS1 832-13, HADHSC silencing resulted in elevated insulin release at low and at high glucose concentrations, which appeared not to be caused by increased rates of glucose metabolism or an inhibition in fatty acid oxidation. These data indicate that the normal beta cell phenotype is characterized by a high expression of HADHSC and a low expression of other -oxidation enzymes. Down-regulation of HADHSC causes an elevated secretory activity suggesting that this enzyme protects against inappropriately high insulin levels and hypoglycemia.

Received for publication, January 3, 2007 , and in revised form, April 13, 2007.

^* This work was supported by the Research Foundation Flanders (FWO-Vlaanderen) Grants G.0357.03 (to D. P.) and G.0529.05 (to F. S. and D. P.), a Ph.D. fellowship (to G. A. M.), and by the Inter-University Poles of Attraction Program IUAP P5/17 from the Belgian Science Policy. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The on-line version of this article (available at http://www.jbc.org) contains supplemental Figs. S1 and S2.

¹ To whom correspondence should be addressed. Tel.: 32-2-4774541; Fax: 32-2-4774545; E-mail: Daniel.Pipeleers{at}vub.ac.be.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				S. Di Candia, A. Gessi, G. Pepe, P. Sogno Valin, E. Mangano, G. Chiumello, L. Gianolli, M. C. Proverbio, and S. Mora Identification of a diffuse form of hyperinsulinemic hypoglycemia by 18-fluoro-L-3,4 dihydroxyphenylalanine positron emission tomography/CT in a patient carrying a novel mutation of the HADH gene Eur. J. Endocrinol., June 1, 2009; 160(6): 1019 - 1023. [Abstract] [Full Text] [PDF]

				C James, R R Kapoor, D Ismail, and K Hussain The genetic basis of congenital hyperinsulinism J. Med. Genet., May 1, 2009; 46(5): 289 - 299. [Abstract] [Full Text] [PDF]

				H. Ellingsgaard, J. A. Ehses, E. B. Hammar, L. Van Lommel, R. Quintens, G. Martens, J. Kerr-Conte, F. Pattou, T. Berney, D. Pipeleers, et al. Interleukin-6 regulates pancreatic {alpha}-cell mass expansion PNAS, September 2, 2008; 105(35): 13163 - 13168. [Abstract] [Full Text] [PDF]